Navigation Links
Virginia Bioinformatics Institute to develop petascale computer modeling capabilities
Date:7/6/2009

Blacksburg, Va. The National Science Foundation (NSF) has awarded a four-year, $1,450,000 grant to the Network Dynamics and Simulation Science Laboratory (NDSSL) at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and partners to develop petascale computing environments that model billions of individuals in extremely large social and information networks.

The anticipated arrival of high-performance computers that routinely perform one quadrillion (one million billion) operations per second means that complex studies of global populations at the level of the individual can realistically be simulated on distributed computer networks. The goal of the proposal "Coupled Models of Diffusion and Individual Behavior Over Extremely Large Social Networks" is to use new computer technology breakthroughs to study events like disease pandemics, financial crises, as well as the spread of opinions, attitudes or social beliefs, through populations on a global scale. Current state-of-the-art agent-based computer models can simulate the spread of a disease like influenza through a population the size of the United States. Petascale modeling would make comparable agent-based studies of disease transmission possible for global populations.

The NDSSL will work with partners at the Brookings Institution, Indiana University, Northwestern University, and the University of Illinois at Urbana-Champaign, to develop models and algorithms that support the work of researchers, policy- and decision-makers who want to examine and probe individual and group behaviors in these extremely large global social networks.

Madhav Marathe, Deputy Director of the NDSSL and Professor in the Department of Computer Sciences at Virginia Tech and Principal Investigator on the proposal, remarked: "Underpinning this project is a desire to create some of the next-generation computational tools and environments that will be needed to enable future research by social, biol
'/>"/>

Contact: Barry Whyte
whyte@vbi.vt.edu
540-231-1767
Virginia Tech
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Virginia Tech Report Has National Importance
2. Virginia Tech Review Panel Calls For Reform of Mental Health Treatment Law
3. Patient Advocate Foundation Launches Program to Help Uninsured Virginians with Chronic, Debilitating and Life-Threatening Illness Access Quality Healthcare
4. Virginia Techs Raving First Year Results Lead to Additional High-Tech Antimicrobial Defense from SportCoatings(TM)
5. Thomson Healthcare Endorsed as Preferred Vendor of Information Products and Services for Virginia Hospitals
6. Virginia Faith Leaders Call on Senators Webb & Warner to Cosponsor Legislation to Protect Kids from Tobacco
7. Anthem Blue Cross and Blue Shield in Virginia Introduces New Generation of Consumer Driven Health Products
8. The Virginia G. Piper Charitable Trust and Flinn Foundation launch
9. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
10. States Largest Medicaid Managed Care Plan Offering Training to Combat West Virginia Obesity Epidemic
11. Virginia Attorney General Addresses Drunk Driving and Underage Drinking in New Radio Campaign

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... the heart is stopped and restarted, the patient,s...ently damaged. Therapeutic hypothermia, a treatmen...ed and maintained several degrees below normal for...e harmful effects and improve survival in adults. ...y of its kind, physician-scientists are evaluating...
(Date:12/3/2009)...a day is still too many - stalled momentum puts mi... Atlanta, GA, Geneva, New York, NY and Washi...Initiative announced today that measles deaths wor...estimated 733 000 in 2000 to 164 000 in 2008. Howe...nce in measles deaths if vaccination efforts are n...
(Date:12/3/2009)...xposed to smoke are at risk of lung cancer , ...lorectal cancer to the list of malignancies caused...nk between the two. , And other studies are pro...d to quit: Two papers published in the December is..., a themed issue on tobacco, strengthen the case f...
(Date:12/3/2009)...PRNewswire/ -- To help children better understand ...ent contracting all forms of influenza, a new anim... Molly and the Flu . ,, The DVD was created by...AHEC), which is part of the Area Health Education ..., The U.S. Centers for Disease Control and Prev...
(Date:12/3/2009)...swire/ -- This holiday season, families tired of w...neck pain are putting a different kind of gift und...through minimally-invasive endoscopic surgery is n...er Spine Institute (LSI). With surgical facilitie...volutionizing spinal procedures using a signature ...
Breaking Medicine News(10 mins):Health News:Cooling may benefit children after cardiac arrest 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 2Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 3Health News:Global Measles Deaths Drop By 78%, But Resurgence Likely 4Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 2Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 3Health News:Smoking Exposure Now Linked to Colon, Breast Cancers 4Health News:New Animated DVD Helps Children to Better Understand and Prevent Contracting the Flu 2Health News:Give the Gift of Relief for the New Year 2
...ing prostate cancer screen less useful, but some e...thDay News) -- Changes in medical practice have un...n (PSA) test as a diagnostic tool for prostate can... annual screening for prostate cancer for most men...
...um,Pharmaceuticals, Inc. (Nasdaq: MLNM ) today an...ny 28th Annual Healthcare Conference will be webca...ors section of the Company,s,website, http://www....b) for,Injection and product candidates in the dev...
... Non-Branded Web site, Best Branded Pharmac... WEST CONSHOHOCKEN, Pa., March 10 Cadient Group,...y serving the healthcare,industry, announced today...ards Dinner on April 17, 2008., "We are excited a...
...c. (NYSE:,NTY) (http://www.NBTY.com ), a leading ...pplements, today announced that it will web cast t...ef Financial Officer of,NBTY, at the Bank of Ameri....nbty.com on Tuesday, March 11, 2008 at 2:30 PM E...
...nts are now utilized,in thousands of consumer prod...a self-described ,tea think-tank, notes that non-b...redients now outnumber beverage,tea offerings on a... including, skincare preparations, functional,food...
...dical Technologies,today announced that the TETRA(...iven clearance to proceed with marketing efforts f...the US Food and Drug Administration,(USFDA)., Lab... be made available to the broadest urological and ...
Other Medicine News:Health News:PSA Test Losing Diagnostic Value, Study Says 2Health News:PSA Test Losing Diagnostic Value, Study Says 3Health News:Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation 2Health News:Cadient Group Receives Multiple Nominations for 2008 DTC National Advertising Awards 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 2Health News:NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares 3Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 2Health News:Tea Ingredients Publication Serves Robust Global Demand for Tea-Based Products 3Health News:Laborie Medical Technologies Receives FDA Pre-Market Clearance for TETRA(TM)- NIRS Accessory for the US Market 2
(Date:12/3/2009)... , HOERSHOLM, Denmark and SAN DIEGO, Cal...PC3649 Successfully Inhibits miR-122, a microRNA I...y Significantly Reducing Hepatitis C,Virus in the ...th the,Hepatitis C Virus , - SPC3649 Demo...ance and,No Serious Adverse Events in the Treated ...
(Date:12/3/2009)..., SAN DIEGO, Dec. 3 Card...y that its wholly-owned subsidiary, Tissue Repair ... filing with the U.S. Food and Drug Administration...en (TM) product candidate based on positive data ...rix clinical study. Today,s submission with the F...
(Date:12/3/2009)...PALO ALTO, Calif., Dec. 3 /PRNewswire-FirstCall/ -...unced today that Kathryn E. Falberg has been appoi...icer. Ms. Falberg brings to Jazz Pharmaceuticals ...or experience. As Jazz Pharmaceutical,s CFO, Ms. ...unting, corporate finance, financial planning, inv...
Breaking Medicine Technology:New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 2New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 3New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 4New Data Shows Breakthrough microRNA-Targeted Therapy Developed Using Santaris Pharma A/S Proprietary LNA Technology Holds Promise as New Treatment for Hepatitis C 5Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 2Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 3Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 4Cardium Files FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Topical Gel and ExcellagenFX(TM) Flowable Collagen Protein-Based Matrix for Diabetic, Pressure and Venous Ulcers and Other Dermal Wounds 5Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 1Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 2Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 3Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 4Wound Management Technologies 28OTCBB 3A WNDM 29 Reports Revenue Increase of 33 5 25 3B Posts Evidence Based Studies for CellerateRx 3B and Business 6462 5Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 1Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 2Drug side effects a key factor in reduced quality of life for kidney transplant patients 61930 3Amid the flu epidemic dont forget RSV in young children 61928 1Amid the flu epidemic dont forget RSV in young children 61928 2Amid the flu epidemic dont forget RSV in young children 61928 3
...ery from EAP in 2007, RICHMOND, Va., Jan. 24 Ins...biologics and biopharmaceuticals, today,provided a...(EAP) in Italy,for the treatment of Amyotrophic La...s grown to include 15 physicians and approximately...Additional subjects continue to be,enrolled into t...
...nt Rotavirus, NEW YORK, Jan. 23 Paul Capital Hea...yalty interest in Rotarix(R) from,Cincinnati Child...al,vaccine developed to prevent rotavirus infectio... and dehydration in infants and young children.,Th... has been approved in,over 100 countries including...
Other Medicine Technology:Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis 2Insmed Provides Update on IPLEX(TM) Expanded Access Program in Italy for the Treatment of Amyotrophic Lateral Sclerosis 3Paul Capital Healthcare Purchases Additional Royalty Interest in GlaxoSmithKline's Rotarix(R) 2
Halogen Lightsources
CMX2-300
NSL-8
NSL-5
Medicine Products: